Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
26P Efficacy and safety of tislelizumab combined with con... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
26P Efficacy and safety of tislelizumab combined with concurrent chemoradiotherapy for high risk locally advanced cervical cancer
0
Authors
Shihong Ma
7 more
Shihong Ma
•
Yunbo Zhang
5 more
•
Zhenzhou Yang
Published
June 1, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
ESMO Open
Topics
Medicine
Cancer Oncology
Internal Medicine
Obstetrics And Gynecology
Chemoradiotherapy
Show all topics
DOI
10.1016/j.esmoop.2024.103526
License
CC-BY-NC-ND
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
ESMO Open
Topics
Medicine
Cancer Oncology
Internal Medicine
Obstetrics And Gynecology
Chemoradiotherapy
Show all topics
DOI
10.1016/j.esmoop.2024.103526
License
CC-BY-NC-ND
Other Formats
PDF
